Protein tyrosine phosphatase 1B is an important therapeutic target for several human diseases, including type 2 diabetes, obesity and cancer. A large number of molecules of broad chemical diversity have been reported as potent and selective PTP1B inhibitors that are superior to other protein tyrosine phosphatases. Some of these molecules have shown their potential to treat a variety of human diseases in various animal models, but only a very limited number of PTP1B inhibitors have entered clinical trials. Therefore, the development of potent, highly selective and safe PTP1B inhibitors remains imperative and important.
BOC Sciences has developed a library to provide potential small-molecule inhibitors of PTP1B.
Figure 1. Binding mode of compounds 1, 2 and 3 in PTP1B. (Akinleye, A.; et al. 2013)
Figure 2. Two dimensional maps of interaction from the complexes PTP1B-1. (Akinleye, A.; et al. 2013)
BOC Sciences provides professional, rapid and high-quality services of Protein-tyrosine Phosphatase 1B (PTP1B) Inhibitors Library design at competitive prices for global customers. Personalized and customized services of Protein-tyrosine Phosphatase 1B (PTP1B) Inhibitors Library design can satisfy any innovative scientific study demands. Our clients have direct access to our staff and prompt feedback to their inquiries. If you are interested in our services, please contact us immediately!
Reference
BOC Sciences has rich experience in working with global customers in custom library synthesis of compounds and generating small to medium-sized libraries of target compounds. Our knowledge in generating a large number of target molecules in a remarkably shorter time enables quick biological screenings for affinities. With the target properties in mind, we deliver target molecules, by applying our extensive knowledge in drug discovery.